Find Clinical Trials & Studies
ENO for non-ventilated COVID
I'm Interested!
Proof of Concept Safety Trial for S-Nitrosylation Therapy to Improve Oxygenation Status in Severe Covid-19 Patients Receiving Supplemental Oxygen Support
- Sex at Birth: Any
- Age: Adult (18 - 64), Older Adult (65+)
- Accepting Healthy People: No
- Type: Interventional / Therapeutic
- Trial Phase: Phase I
- Conditions Being Studied: Other Respiratory and Intrathoracic Organs, COVID-19
Study Purpose
ENO treatment has the potential to significantly improve the clinical management of patients with COVID-19 who are experiencing lung injury. In sum, ENO is a novel drug and its inhalation constitutes a unique therapeutic approach that has the potential to provide distinctive benefits to COVID-19 patients.
Locations
UH Cleveland Medical Center
11100 Euclid Avenue
Cleveland OH, 44106
- UH IRB: STUDY20210599
- StudyID: 2021-0744
- ClinicalTrials.gov: NCT04528771
I'm Interested!
Questions or concerns? We're here to help.
Non-cancer Trials: 1-833-78TRIAL or Contact Us Online
Cancer Trials: 1-800-641-2422